IL1B and atrial fibrillation: We treated the cells with BIO (6‐bromoindirubin‐3′oxime), a GSK‐3β inhibitor, and found that BIO, as well as IL‐1β significantly upregulated β‐catenin protein levels in rat AF and NP cells.